A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects

NCT04809818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: LT3001 drug product
DRUG: Placebo
DRUG: Aspirin
DRUG: Clopidogrel
DRUG: Apixaban
DRUG: Dabigatran

Sponsor

Lumosa Therapeutics Co., Ltd.